MARK L PERRY Insider Trading $GBT Global Blood Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK L PERRY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK L PERRY. MARK L PERRY is Director in ARCA biopharma, Inc. ($ABIO) and Director in NVIDIA CORP ($NVDA) and Director in MyoKardia Inc ($MYOK) and Director in Global Blood Therapeutics, Inc. ($GBT).
MARK L PERRY in Global Blood Therapeutics, Inc.
Trading Symbol: GBTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK L PERRY: Director
Holdings: 31,228 shares
Current Value: $505,894
Latest Transaction: Jun 19 2020
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK L PERRY in Global Blood Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABIO, GBT, MYOK, NVDA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 0.00 | 3,037 | 0 | 3,037 | |
Jun 19 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 0.00 | 3,037 | 0 | 3,037 | |
Jun 19 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 64.75 | 5,247 | 339,743 | 5,247 | |
Jun 19 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 64.75 | 5,247 | 339,743 | 5,247 | |
Jun 19 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | M | 0.00 | 4,800 | 0 | 0 | |
Jun 19 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | M | 0.00 | 4,800 | 0 | 0 | |
Jun 19 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Buy | M | 0.00 | 4,800 | 0 | 31,228 | 26.4 K to 31.2 K (+18.16 %) |
Jun 19 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Buy | M | 0.00 | 4,800 | 0 | 31,228 | 26.4 K to 31.2 K (+18.16 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | M | 28.45 | 15,000 | 426,750 | 0 | |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | M | 18.85 | 15,000 | 282,750 | 0 | |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | M | 20.00 | 8,600 | 172,000 | 0 | |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | M | 20.00 | 15,000 | 300,000 | 0 | |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Sell | S | 79.17 | 1,295 | 102,522 | 26,428 | 27.7 K to 26.4 K (-4.67 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Sell | S | 78.65 | 34,698 | 2,728,932 | 27,723 | 62.4 K to 27.7 K (-55.59 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Sell | S | 77.71 | 13,024 | 1,012,138 | 62,421 | 75.4 K to 62.4 K (-17.26 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Sell | S | 76.28 | 600 | 45,771 | 75,445 | 76 K to 75.4 K (-0.79 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Sell | S | 75.43 | 1,350 | 101,833 | 76,045 | 77.4 K to 76 K (-1.74 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Sell | S | 74.01 | 2,633 | 194,865 | 77,395 | 80 K to 77.4 K (-3.29 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Buy | M | 28.45 | 15,000 | 426,750 | 80,028 | 65 K to 80 K (+23.07 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Buy | M | 18.85 | 15,000 | 282,750 | 65,028 | 50 K to 65 K (+29.98 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Buy | M | 20.00 | 8,600 | 172,000 | 50,028 | 41.4 K to 50 K (+20.76 %) |
May 13 2020 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Buy | M | 20.00 | 15,000 | 300,000 | 41,428 | 26.4 K to 41.4 K (+56.76 %) |
Jun 20 2019 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 0.00 | 4,800 | 0 | 4,800 | |
Jun 20 2019 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 56.30 | 7,500 | 422,250 | 7,500 | |
Jun 22 2018 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 42.25 | 15,000 | 633,750 | 15,000 | |
Jun 22 2017 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 28.45 | 15,000 | 426,750 | 15,000 | |
Jan 07 2016 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Buy | P | 20.00 | 5,000 | 100,000 | 26,428 | 21.4 K to 26.4 K (+23.33 %) |
Aug 13 2015 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 20.00 | 8,600 | 172,000 | 8,600 | |
Aug 13 2015 | GBT | Global Blood Thera ... | PERRY MARK L | Director | Option Exercise | A | 20.00 | 15,000 | 300,000 | 15,000 |
Page: 1